Sensitivity to EGFR inhibitors based on location of EGFR exon 20 insertion mutations within the tyrosine kinase domain of EGFR.

被引：0
|
作者：
Costa, Daniel Botelho
Yasuda, Hiroyuki
Sng, Natasha J.
Yeo, Wee-Lee
de Figueiredo-Pontes, Lorena Lobo
Tenen, Daniel G.
Kobayashi, Susumu
机构：
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7523
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Discovery and Optimization of Potent, Efficacious and Selective Inhibitors Targeting EGFR Exon20 Insertion Mutations
    Thomson, Clare
    Barton, Peter
    Braybrooke, Erin
    Colclough, Nicola
    Dong, Zhiqiang
    Evans, Laura
    Floc'h, Nicolas
    Guerot, Carine
    Hargreaves, David
    Khurana, Puneet
    Li, Songlei
    Li, Xiuwei
    Lister, Andrew
    McCoull, William
    McWilliams, Lisa
    Orme, Jonathan P.
    Packer, Martin J.
    Swaih, Aisha M.
    Ward, Richard A.
    Winlow, Poppy
    Ye, Yang
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 8988 - 9027
  • [42] EGFR Exon 20 Insertion/Duplication Mutations Characterize Fibrous Hamartoma of Infancy
    Park, Jason Y.
    Cohen, Cynthia
    Lopez, Dania
    Ramos, Erica
    Wagenfuehr, Jennifer
    Rakheja, Dinesh
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (12) : 1713 - 1718
  • [43] Clinical characteristics, treatment patterns and outcomes of EGFR exon 20 insertion and other EGFR mutations in Korean aNSCLC patients
    Yoon, S.
    Lim, S. M.
    Jung, H. A.
    Kim, K-P.
    Kim, D.
    Jeong, H.
    Lim, S.
    Kim, J.
    Kim, J.
    Patel, D.
    Zhao, X.
    Horsburgh, D.
    Yu, D. Y.
    Kim, J. H.
    Kim, S. Y.
    Lee, D. H.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 : S56 - S56
  • [44] Resistance mechanisms to mobocertinib in treating NSCLC with EGFR exon 20 insertion mutations
    Le, Xiuning
    Nilsson, Monique
    Chatterjee, Sampurna
    Su, Zhenqiang
    He, Junqin
    Udagawa, Hibiki
    Yu, Xiaoxing
    Poteete, Alissa
    Huang, Qian
    Heymach, John V.
    Vincent, Sylvie
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [45] Preclinical Characterization of Mobocertinib Highlights the Putative Therapeutic Window of This Novel EGFR Inhibitor to EGFR Exon 20 Insertion Mutations
    Vasconcelos, Pedro E. N. S.
    Kobayashi, Ikei S.
    Kobayashi, Susumu S.
    Costa, Daniel B.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (03):
  • [46] The EGFR C797S Mutation Confers Resistance to a Novel EGFR Inhibitor CLN-081 to EGFR Exon 20 Insertion Mutations
    Kagawa, Yosuke
    Hayashida, Takuma
    Liu, Jie
    Mori, Shunta
    Izumi, Hiroki
    Kumagai, Shogo
    Udagawa, Hibiki
    Hattori, Noboru
    Goto, Koichi
    Kobayashi, Susumu S.
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (03):
  • [47] Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma
    Giuseppina Improta
    Angela Zupa
    Maria Iole Natalicchio
    Lorenza Sisinni
    Anna Marinaccio
    Giovanni Bozza
    Giulia Vita
    Michele Aieta
    Matteo Landriscina
    [J]. Medical Oncology, 2018, 35
  • [48] Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma
    Improta, Giuseppina
    Zupa, Angela
    Natalicchio, Maria Iole
    Sisinni, Lorenza
    Marinaccio, Anna
    Bozza, Giovanni
    Vita, Giulia
    Aieta, Michele
    Landriscina, Matteo
    [J]. MEDICAL ONCOLOGY, 2018, 35 (03)
  • [49] Detection of mutations in the EGFR tyrosine kinase domain by DNA sequencing.
    Da Silva, M.
    Flynn, K. E.
    Choppa, P.
    Zhou, Z.
    Bell, D. W.
    Iafrate, A. J.
    Paler, R. J.
    Allitto, B. A.
    Rohlfs, E. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 555S - 555S
  • [50] Efficacy of EGFR tyrosine kinase inhibitors in patients having EGFR-activating mutations with or without BIM polymorphisms
    Ariyasu, Ryo
    Yanagitani, Noriko
    Tadokoro, Kenichi
    Yamaguchi, Toshikazu
    Uchibori, Ken
    Kitazono, Satoru
    Fujita, Naoya
    Katayama, Ryohei
    Nishio, Makoto
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (04) : 517 - 525
12345